Key result
Adenovirus 36 seropositivity shows a non-significant trend toward greater odds of obesity.
Why the study?
The seroprevalence of adenovirus 36 among Hispanic-American youth and its association with obesity risk and response to health interventions had not been examined.
Does Ad36 seropositivity impact obesity risk and response to a 16-week health intervention in Hispanic-American middle-school students?
Observational (n=40)
No
Does Ad36 seropositivity impact obesity risk and response to a 16-week health intervention in Hispanic-American middle-school students?
There is a high seroprevalence of Ad36 among Hispanic-American youth, which showed a non-significant trend toward greater likelihood of obesity but did not impact weight loss response to a health intervention.
Answers are grounded in this paper and cite their sources.
High Ad36 seroprevalence with nonsignificant obesity trend in Hispanic youth; leaves open causal role and intervention effects for larger studies.
Infection with adenovirus 36 (Ad36) has been associated with risk of obesity in youth in some studies, but the seroprevalence of this virus has not been examined among all populations. As Hispanic-American youth are of greater risk for obesity than other American youth, we sought to determine the proportion of Ad36 seropositive (Ad36+) students in an urban middle school serving a Hispanic population. We further examined if Ad36+ students were more likely to have obesity, and if Ad36 serostatus impacted changes in weight status following a health intervention. We determined body mass index (BMI) at the beginning and end of a 16-week health intervention among 40 Hispanic-American middle-school students. Ad36 serostatus was determined by enzyme-linked immunsorbent assay (ELISA). Seventy percent of the students were Ad36+. Ad36+ and Ad36 seronegative (Ad36-) did not differ before or after the intervention in body weight measures. The odds of being classified as obese was 1.4 times greater among Ad36+ than Ad36- at baseline, and 2.4 times greater post-intervention, but these were not statistically significant. We report a high seroprevalence of Ad36 among a population of Hispanic-American students. Ad36 seropositivity was associated with a trend for a greater likelihood of having obesity, but did not impact response to a health intervention.
No takes yet. Share an insight, caveat, or question.
LaVoy et al. (2018) conducted an observational in Obesity (n=40). Adenovirus 36 (Ad36) seropositivity vs. Ad36 seronegativity was evaluated on Odds of being classified as obese at baseline (OR 1.4, p=not significant). Adenovirus 36 seropositivity was associated with a non-significant trend for greater odds of obesity at baseline and post-intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: